113 related articles for article (PubMed ID: 2545229)
1. The Hodgkin-associated Ki-1 antigen exists in an intracellular and a membrane-bound form.
Hansen H; Lemke H; Bredfeldt G; Könnecke I; Havsteen B
Biol Chem Hoppe Seyler; 1989 May; 370(5):409-16. PubMed ID: 2545229
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase activity of the intracellular but not of the membrane-associated form of the Ki-1 antigen (CD30).
Hansen H; Bredfeldt G; Havsteen B; Lemke H
Res Immunol; 1990 Jan; 141(1):13-31. PubMed ID: 2161115
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines.
Froese P; Lemke H; Gerdes J; Havsteen B; Schwarting R; Hansen H; Stein H
J Immunol; 1987 Sep; 139(6):2081-7. PubMed ID: 3040864
[TBL] [Abstract][Full Text] [Related]
4. Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus.
Rohde D; Hansen H; Hafner M; Lange H; Mielke V; Hansmann ML; Lemke H
Am J Pathol; 1992 Feb; 140(2):473-82. PubMed ID: 1310832
[TBL] [Abstract][Full Text] [Related]
5. Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis.
Pfreundschuh M; Pohl C; Berenbeck C; Schroeder J; Jung W; Schmits R; Tschiersch A; Diehl V; Gause A
Int J Cancer; 1990 May; 45(5):869-74. PubMed ID: 2159438
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and structural properties of a Hodgkin's disease-related membrane protein.
Nawrocki JF; Kirsten ES; Fisher RI
J Immunol; 1988 Jul; 141(2):672-80. PubMed ID: 3385212
[TBL] [Abstract][Full Text] [Related]
7. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
Andreesen R; Brugger W; Löhr GW; Bross KJ
Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.
Herbst H; Tippelmann G; Anagnostopoulos I; Gerdes J; Schwarting R; Boehm T; Pileri S; Jones DB; Stein H
Leuk Res; 1989; 13(2):103-16. PubMed ID: 2538681
[TBL] [Abstract][Full Text] [Related]
9. Ki-1 positive meningeal lymphoma in a patient with a history of Hodgkin lymphoma.
Serena M; Tonetto G; Belli P
Ital J Neurol Sci; 1991 Feb; 12(1):93-7. PubMed ID: 1849505
[TBL] [Abstract][Full Text] [Related]
10. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
11. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells.
Yu Y; Rabinowitz R; Polliack A; Ben-Bassat H; Schlesinger M
Eur J Haematol; 2002 Jan; 68(1):22-30. PubMed ID: 11952818
[TBL] [Abstract][Full Text] [Related]
12. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of 26 cases of Ki-1 lymphomas: morphoimmunologic correlation.
Rivas C; Piris MA; Gamallo C; Barat A; Echezarreta G; Oliva H; Sarasa JL; Rivas F; Renedo G; Martin C
Ultrastruct Pathol; 1990; 14(5):381-97. PubMed ID: 2174195
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.
Pizzolo G; Vinante F; Chilosi M; Dallenbach F; Josimovic-Alasevic O; Diamantstein T; Stein H
Br J Haematol; 1990 Jun; 75(2):282-4. PubMed ID: 2164839
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.
Tomita Y; Arakawa F; Yamamoto T; Kuwahara M; Watanabe R; Iwasaki H; Kikuchi M; Kuroki M
Jpn J Cancer Res; 2000 Feb; 91(2):231-8. PubMed ID: 10761711
[TBL] [Abstract][Full Text] [Related]
16. High incidence of monoclonal EBV episomes in Hodgkin's disease and anaplastic large-cell KI-1-positive lymphomas in HIV-1-positive patients.
Boiocchi M; De Re V; Gloghini A; Vaccher E; Dolcetti R; Marzotto A; Bertola G; Carbone A
Int J Cancer; 1993 Apr; 54(1):53-9. PubMed ID: 8386709
[TBL] [Abstract][Full Text] [Related]
17. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
18. [Ki-1 lymphoma histologically mimicking Hodgkin's disease].
Watanaba K; Naito M; Tanahashi N; Nara M; Kobayashi H; Shimbo T; Kojima M
Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):964-5. PubMed ID: 2551983
[No Abstract] [Full Text] [Related]
19. A novel B cell line established from Ki-1-positive diffuse large cell lymphoma.
Kamesaki H; Miwa H; Ohno Y; Miyanishi S; Yamabe H; Doi S; Arita Y; Ohno H; Tatsumi E; Nishikori M
Jpn J Cancer Res; 1988 Nov; 79(11):1193-200. PubMed ID: 2852183
[TBL] [Abstract][Full Text] [Related]
20. Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).
Horn-Lohrens O; Tiemann M; Lange H; Kobarg J; Hafner M; Hansen H; Sterry W; Parwaresch RM; Lemke H
Int J Cancer; 1995 Feb; 60(4):539-44. PubMed ID: 7530238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
